Skip to content

The effects of bread containing Fenugreek on health of patients with type 2 diabetes mellitus

The effects of bread containing Fenugreek and Cinnamon on anthropometric indices, glycemic status and lipid profile in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110314006065N4
Enrollment
90
Registered
2022-02-21
Start date
2021-12-23
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diebetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: Group consumes a toast containing fenugreek and cinnamon. Baked bread will replace 4 units of common bread and the study will continue for 8 weeks. Carbohydrates wi

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes (fasting blood sugar less than or equal to 126 Milligrams in deciliter and two-hour blood sugar greater than or equal to 200 Milligrams in deciliter) Receiving blood sugar lowering drugs HbA1c more than 10% Body mass index less than 40 kilogram in square meter

Exclusion criteria

Exclusion criteria: Insulin or liraglutide injection Type 1 diabetes History of chronic liver and kidney disease, diabetic foot ulcer, various malignancies, rheumatic and infectious diseases • Take any herbal medicine or herbal medicine to control blood sugar at present History of any allergies to herbs Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.

Secondary

MeasureTime frame
HbA1c. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: En Chromatography.;Weight. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Scales.;Total cholesterol. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazli Namazi

Tehran University of Medical Sciences

nazli.namazi@yahoo.com+98 919 241 4658

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026